LEXINGTON, Mass. & SYDNEY--(BUSINESS WIRE)--GI Dynamics, Inc. (ASX: GID), a company pioneering the development of effective non-surgical approaches for treating type 2 diabetes and obesity, today announced that it has designated the Heart and Diabetes Center North Rhine-Westphalia at Bad Oeynhausen and the Universitätsmedizin Mannheim as the newest Centers of Excellence (COEs) in Germany. Together, they join Universitätsklinikum Hamburg-Eppendorf as the only COEs in Germany to currently offer the EndoBarrier® Gastrointestinal Liner (the EndoBarrier), a novel approach for the treatment of type 2 diabetes and/or obesity. A hospital is certified as an EndoBarrier COE after meeting initial qualifications of having a team experienced in treating patients with type 2 diabetes and obesity and following a rigorous training and proctorship program conducted by GI Dynamics.
